PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Renoprotective effect of vildagliptin following hepatic ischemia/reperfusion injury.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32102588 ↗2020Reported benefit

Renoprotective effect of vildagliptin following hepatic ischemia/reperfusion injury.

RatIschaemia-reperfusionHepaticWistarMalen = Three groups of male Wistar rats (sham, ischaemia/reperfusi…Intraperitoneal10 mg/kg/dayPretreatment for 10 days before hepatic ischaemia/reperfusion

Model: Hepatic ischaemia/reperfusion with remote renal injury

Vildagliptin significantly improved the biochemical markers of remote renal injury and the histopathological changes after hepatic ischaemia/reperfusion, and blocked the upregulation of renal TGF-beta/Smad/alpha-SMA mRNA expression.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.